| | | | | | | | | | | | | | | | | |
| | | | Three Months Ended March 31, |
| Financial statement caption | | 2025 | | 2024 |
| Non-Designated Derivative Instruments | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| Unrealized (gains) losses | Other (income) expense, net | | $ | (2) | | | $ | 46 | |
| Designated Derivative Instruments | | | | | |
| Realized (gains) losses | Interest and debt (income) expense | | $ | (8,194) | | | $ | (14,545) | |
| Unrealized (gains) losses | Comprehensive (income) loss | | $ | 16,109 | | | $ | (37,690) | |
| | | | | |
| | | | | |
